Table 5. Statistical summary of PCSK9 data in atorvastatin treated vs. normal subject.
Analysis Parameters | Group 1 Normal Subjects (n = 80) |
Group 2 40mg/Day Atorvastatin (n = 25) |
Group 3 80mg/Day Atorvastatin (n = 30) |
---|---|---|---|
Mean (ng/mL) | 404 | 641 | 751 |
STD | 164.1 | 141.3 | 244.4 |
%CV | 41 | 22 | 33 |
Median (ng/mL) | 390 | 668 | 705 |
Min (ng/mL) | 120 | 347 | 424 |
Max (ng/mL) | 800 | 933 | 1445 |
%CV: coefficient of variation calculated as (STD/mean concentration) × 100; STD